|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 关于导致心脏病终末期因素的新概念显示文摘关于导致心脏病终末期因素的新概念[CohnJN.CardiovascOrugsTher,1995,9:489(英文)]不论其原发病因如何,心脏病总是向前发展的。慢性容量负荷过重如二尖瓣关闭不全,可代偿数年直至左心室出现一些内在因素而进入不可逆转的阶段... | Cohn JN | 1996 | 心血管病学进展1996，17，5： | 2 |
| 2 | 血管扩张剂治疗心力衰竭的未来指向显示文摘近10年来,对心脏衰竭血管扩张剂联合治疗的有利血流动力学效用和作用机理等的研究,取得了进展。未来的指向将是血管收缩新机理的探讨,从而研制新的、理想的血管扩张剂,以取得治疗的新突破。 | Cohn JN 何玉泉 | 1991 | 国外医学(心血管疾病分册)1991，18，6： | 2 |
| 3 | Arterial elasticity as part of a comprehensive assessmen to cardiovascular risk and drug treatment 显示文摘 | Cohn JN DuprezDA Grandits GA | 2005 | Hypertension2005，46，7： | 1 |
| 4 | Arteries myocardium blood pressure and cardiovascular risk:towards a revised definition of hypertension显示文摘 | Cohn JN | 1998 | Am J Hypertens1998，16，122： | 1 |
| 5 | The effect of carvedilol on morbidity and mortality in patients with chronic heart failure显示文摘 | Packer M Brstow MR Cohn JN | 1996 | N Engl J Med1996，334，： | 1 |
| 6 | Cardiac remodeling concepts and clinical implications:a consensus paper from an international forum on cardiac remodeling显示文摘 | Cohn JN Ferrari R Sharpe N | 2000 | J Am Coll Cardiol2000，35，3： | 1 |
| 7 | ACE inhibition and vascular remodeling of resistance vessels: Vascular compliance and cardiovascular implications 显示文摘 | Cohn JN | 2000 | Heart Dis2000，2，2： | 1 |
| 8 | Rationale and design of the Valsartan Heart Failure Trial:a large multinational trial to assess the effects of valsartan,an angiotensin-receptor blocker,on morbidity and mortality in chronic congestive heart failure显示文摘 | Cohn JN Tognoni G Glazer RD | | 0，，02： | 1 |
| 9 | Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment显示文摘 | Cohn JN Duprez DA Grandits GA | 2010 | Hypertension2010，46，1： | 1 |
| 10 | The management of chronic heart failure显示文摘 | | 1996 | N Engl Med1996，335，： | 1 |
| 11 | Cardiac remodeling concepts and clinic implications: a consensus paper from an international forum on cardiac remodeling显示文摘 | Ferrari t Sharpe N | 2000 | JACC2000，35，： | 1 |
| 12 | Cardiovascular effects of aldostemne and post-acute myocardial infarction pathophysiology显示文摘 | Cohn JN Colucci W | 2006 | Am J Cardiol2006，97，10： | 1 |
| 13 | Consensus recommendations for the management of chronic heart failure显示文摘 | Packer M Cohn JN Abraham WT | 1999 | Am J Cordial1999，83，2： | 1 |
| 14 | Effects of sustained-release moxonidine,an imidazoline agonist,on plasma norepinephrine in patients with chronic heart failure显示文摘 | Swedberg K Bristow MR Cohn JN | 2002 | Circulation2002，105，： | 1 |
| 15 | Arterial compliance to stratify cardiovascular risk: More preci- sion in therapeutic decision making 显示文摘 | Cohn JN | 2001 | Am J Hypertens2001，14，5： | 1 |
| 16 | Patients' self-assessment of their con- gestive heart failure显示文摘 | Rector TS Kubo S Cohn JN | 1987 | Heart Failure1987，3，： | 1 |
| 17 | A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure显示文摘 | Cohn JN Tognoni G Valsartan Heart Failure Trial Investigators | | 0，，23： | 1 |
| 18 | A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure显示文摘 | Cohn JN Tognoni G | | 0，，23： | 1 |
| 19 | Definition and classification of hypertension:an update显示文摘 | Giles TD Materson BJ Cohn JN | 2009 | J Clin Hypertens(Greenwich)2009，11，11： | 1 |
| 20 | Physiologyical rationable for co-treatment with diuretics in heart failure显示文摘 | Cohn JN | 2002 | Br Heart J2002，72，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员